TIAN CHANG GP (02182) Establishes Integrated Advanced Manufacturing Platform as Core Long-Term Strategy

Stock News
08/12

TIAN CHANG GP (02182) has announced that its board aims to further clarify the company's long-term strategic direction, centering on an "Integrated Advanced Manufacturing Platform." This move comes as the group continues to enhance its capabilities in advanced materials, precision manufacturing, and new product applications.

Over the years, the company has steadily developed core competencies spanning product design and engineering development, precision mold design and fabrication, precision injection molding, surface treatment and coloration, material and surface processing technologies, automated assembly, process engineering, and manufacturing services. This has led to the creation of a comprehensive manufacturing system that covers everything from product development to mass production.

In the field of precision mold design and manufacturing, TIAN CHANG GP has accumulated substantial technical expertise. Its precision molds and injection molding capabilities meet the H-level requirements for high-precision plastic molded parts under the GB/T 47067-2026 standard for "Plastic Moulded Parts - Tolerances and Acceptance Conditions." Leveraging this engineering and manufacturing foundation, the group has long provided services to global brand clients, covering engineering development, mold design, precision manufacturing, and mass production.

The board believes the group's core competitiveness does not rely on any single product or industry. Instead, it stems from its ability to integrate engineering, manufacturing, and mass production capacities, applying them flexibly according to different customer needs and product requirements. Based on this technical and manufacturing base, the company has formally adopted the "Integrated Advanced Manufacturing Platform" as its long-term positioning.

TIAN CHANG GP plans to continue advancing its engineering technology and advanced material capabilities while expanding cross-industry applications. The goal is to gradually build a more balanced and diversified business portfolio, thereby enhancing overall business resilience and long-term competitiveness. The company's existing engineering and manufacturing capabilities are already applied across multiple product areas, including consumer electronics, office furniture, telecommunications products, automotive products, solar energy systems, and other categories.

As a technological extension of its integrated platform, TIAN CHANG GP is developing new capabilities in semi-solid magnesium alloy injection molding (Magnesium Thixomolding). This initiative aims to further expand its advanced materials and lightweight manufacturing capabilities. To support the development of its integrated platform, particularly the semi-solid magnesium alloy injection molding segment, the group is establishing a new manufacturing facility in Huizhou City, Guangdong Province, China.

The board believes that continuously strengthening the group's core manufacturing capabilities, technology platforms, and cross-industry applications will help enhance its long-term competitiveness and business resilience. This strategy is expected to build a more solid and sustainable development foundation, ultimately creating long-term value for shareholders.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10